Corporate Governance | Regeneron Pharmaceuticals Inc.

Date	Name	Title	Filing	Type	Shares Traded	Price	Total Held
Jul 02, 2021	LAROSA JOSEPH J EVP General Counsel and Secret Trans History: 181	EVP General Counsel and Secret	Form 4	Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3	6,602	$582.20	16,580
May 14, 2021	STAHL NEIL EVP Research and Development Trans History: 660	EVP Research and Development	Form 4	Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3	27,775	$516.69	36,505
May 14, 2021	STAHL NEIL EVP Research and Development Trans History: 660	EVP Research and Development	Form 4	Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3	7,204	$516.69	41,801
Feb 23, 2021	VAGELOS P ROY Director Trans History: 742	Director	Form 4	Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3	137,998	$458.48	349,090
Dec 30, 2020	YANCOPOULOS GEORGE Director, President and Chief Scientific Trans History: 628	Director, President and Chief Scientific	Form 4	Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3	130,714	$483.25	750,224
Dec 30, 2020	YANCOPOULOS GEORGE Director, President and Chief Scientific Trans History: 628	Director, President and Chief Scientific	Form 4	Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3	86,096	$483.25	822,207
Nov 16, 2020	MURPHY ANDREW J EVP Research Trans History: 222	EVP Research	Form 4	Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3	7,108	$561.39	53,764
Aug 27, 2020	LAROSA JOSEPH J EVP General Counsel and Secret Trans History: 181	EVP General Counsel and Secret	Form 4	Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3	3,197	$614.87	17,241
Aug 27, 2020	LAROSA JOSEPH J EVP General Counsel and Secret Trans History: 181	EVP General Counsel and Secret	Form 4	Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3	2,131	$614.87	19,110
Aug 20, 2020	Van Plew Daniel P EVP & General Mgr Industrial O Trans History: 359	EVP & General Mgr Industrial O	Form 4	Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3	47,891	$614.09	47,110

* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.

Investors & Media